Hongfeng Gu
11PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 31, 2026
Identification of an Orally Bioavailable Quinoline-Based Small-Molecule Tumor Necrosis Factor α (TNF-α) Inhibitor Featuring a Spirocyclic Scaffold.Zeren Sun, Wenbin Zhang, Wanyong He
|Jan 13, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer.Xingxing Cheng, Zheqi Hu, Huihuan Mao
|Dec 22, 2025
Discovery of PKMYT1 Inhibitors with a Novel Scaffold for the Treatment of Triple-Negative Breast Cancer.Jingling Huang, Peixuan Li, Feihuang Qiu
|Oct 28, 2025
Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia.Wenhui Zhang, Wenxin Yan, Tianyi Wei
|Sep 25, 2025
PARP7: an Emerging Therapeutic Target-Insights into Biological Functions and Advances in Small-Molecule Inhibitor Development.Feihuang Qiu, Jianqiao Wang, Kehan Huang
Pageof 2
![Automated Preparation of [<sup>68</sup>Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=75)
